Prevention of invasive aspergillosis in AIDS by sulfamethoxazole

AIDS

Volumn 15, Issue 8, 2001, Pages 1067-1068

  Afeltra, Javier ^a   Meis, Jacques F C M ^a,b   Mouton, Johan W ^b   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE; SULFAMETHOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TOXOPLASMOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; DAPSONE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENTAMIDINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0035947105     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200105250-00020     Document Type: Article

References (6)

1. 1. El-Sadr WM, Luskin-Hawk R, Yurik TM, et al. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 1999, 29:775-783.
2. 2. Kaplan JE, Masur H, Holmes KK, et al. An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons. Clin Infect Dis 2000, 30 (Suppl. 1):S15-S28.
3. 3. Mylonakis E, Mileno MD, Flanigan T, De Orchis DF, Rich J. Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: report of two cases. Heart Lung 1998, 27:63-66.
4. 4. Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis 1992, 14:141-148.
5. 5. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324:654-662.
6. 6. National Committee for Clinical laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidiun-forming filamentous fungi. Proposed standard M38-P. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.